Ampio Pharma (AMPE) Issues Prelim. Update on Optina Clinical Trial; Concluded Study Ahead of Schedule, to Request Meeting with FDA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/15/2026

1. IBM
2. SPY
3. LCID
4. JPM
5. BAC
6. ERAS
7. AAPL
8. TREX
9. SPCX
10. WFC

Go back to Ampio Pharma (AMPE) Issues Prelim. Update on Optina Clinical Trial; Concluded Study Ahead of Schedule, to Request Meeting with FDA